Kozármisleny, Hungary

Éva Szöke


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Éva Szöke: Innovator in Neurogenic Inflammation Treatments

Introduction

Éva Szöke, an esteemed inventor based in Kozármisleny, Hungary, is known for his significant contributions to the field of pharmaceuticals. With a focus on treating neurogenic inflammation and neuropathic hyperalgesia, Éva has developed innovative solutions that aim to alleviate suffering from these challenging disorders.

Latest Patents

Éva Szöke holds a patent for "Agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders." This patent introduces 4-phenetylamino-7H-pyrrolo[2,3-d]pyrimidine derivatives, along with their solvates, hydrates, and pharmaceutically acceptable salts. The invention encompasses methods for manufacturing these compounds and their application in pharmaceutical compositions. Notably, these compounds have been identified as new drug candidates for preventing and treating acute neurogenic inflammation and neuropathic hyperalgesia, paving the way for advancements in pain management therapies.

Career Highlights

Éva Szöke is affiliated with the University of Pécs, where he leverages his expertise and research capabilities to push the boundaries of pharmaceutical innovation. His dedication to developing effective treatments has not only contributed to his personal achievements but has also significantly advanced the university's reputation as a research institution.

Collaborations

Throughout his career, Éva has collaborated with notable colleagues, including János Szolcsányi and Erika Pintér. These partnerships have fostered a collaborative environment that emphasizes innovation and research excellence, leading to groundbreaking discoveries in the field of neuropharmacology.

Conclusion

Éva Szöke's work exemplifies the spirit of innovation within the pharmaceutical industry. His patent on treating neurogenic inflammation and neuropathic hyperalgesia marks a significant advancement in medical science. As he continues to collaborate and conduct research, Éva remains a pivotal figure in the search for effective treatments, impacting the lives of many individuals suffering from these debilitating conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…